Uniphar (UPR.I, UPR ID)

  • 562.4
  • 273.0
  • 85.8
  • UNIPHAR

    Closing Price (c): 206.0

  • RATING 27/08/19

  • PREVIOUS RATING

Company Profile

Uniphar is a diversified healthcare services business operating across three divisions. The Supply Chain & Retail division is the leading distributor in the pre-wholesale and wholesale markets to retail and hospital pharmacies in Ireland. It also provides unparalleled expertise and support to pharmacy customers across Ireland. The MedTech division holds exclusive distribution agreements with some of the world's preeminent manufacturers of medical devices. The Pharma division provides high value services across the lifecycle of a pharmaceutical product. It is a leading global provider of unlicensed and difficult to source medicines for primary and secondary care customers and improves patient access to medicines in Europe and around the world. The company has a strong organic growth outlook with a highly regarded management team. Uniphar aims to double its EBITDA in the medium term.


Major Shareholders%
Allianz Global Investors12.0
Polar Capital LLP7.3
ROI HealthCo IOM 1 Ltd.4.6
Sisk Family4.6
Mackenzie Financial Corp.4.5